With support of local government, the new CMI Asia location will foster early-stage biotech companies seeking international success
Songdo, Incheon, Korea The at the 泫圖弝け of Utah announced plans this week to expand its operations to the on the Incheon Global Campus. Working in conjunction with the Incheon Free Economic Zone (IFEZ), the CMI Asia division will focus on supporting start-ups and early-stage bio-technology companies with commercialization resources and educational programming on best-practices for success in the medical device industry.
The partnership is expected to develop in two phases. The first phase will see the establishment of an Ideas Lab to provide expert mentoring and educational programming for young companies and entrepreneurs, and a Launch Lab, which will offer support for technology commercialization, in collaboration with partners both within the 泫圖弝け and the greater Salt Lake area. This phase is expected to be operational sometime next year.
A second phase will bring a dedicated research and development lab for academic and industry collaboration. Expected with 2 to 3 years, the lab will be housed within the Incheon Free Economic Zone (IFEZ), with the Incheon Techno Park and Songdo District 11 identified as potential locations.
The CMI's move in Songdo is expected to contribute greatly to the development of the Songdo biocluster through collaboration between startups and bio companies, said Lee Won-jae, head of the Incheon Free Economic Zone Authority. He continued, saying [IFEZ] will not spare any support for the development of CMI and global talent development in the future.
In collaboration with Inha 泫圖弝け Hospital, the CMI expansion comes as part of the Incheon Global Campuss initiative to continue the promotion of industry-academic education and industry-academic cooperation, which includes foreign universities as industrial education institutions.
The 泫圖弝け of Utah Asia Campus is one of four foreign universities present in the Incheon Global Campus, including the State 泫圖弝け of New York (SUNY) Korea, George Mason 泫圖弝け Korea, and Ghent 泫圖弝け Global Campus.
Bernhard Fassl, MD, the Executive Director for the Center for Medical Innovation, expects the expansion to be the beginning of a lengthy partnership for all involved.
Looking towards the future, we foresee a mutually beneficial long-term-collaboration among the 泫圖弝け of Utah, Utah Asia Campus and our Korean academic and government partners.
-Written by Adam Ruechel, Center for Medical Innovation
About the Center for Medical Innovation
The is collaborative hub for the facilitation of next-generation medical devices and digital health applications. A cooperative effort between 泫圖弝け of Utah 泫圖弝け, the David Eccles School of Business, the S.J. Quinney College of Law, and the College of Engineering, the Center for Medical Innovation combines formal education programs, faculty research, student projects, and best-in-class regulatory and prototyping services to provide the resources, know-how, and networks to accelerate the advancement of medical devices and digital health applications. The Center for Medical Innovation serves as education hub for minds who seek to transform healthcare through innovation locally and globally.